| 영문 | advanced cancer | 한글 | 진행암 |
|---|---|---|---|
| 설명 | 조기암에 대한 말로 암의 경과가 진행된 것을 말한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| 영문 | cancer chemotherapy | 한글 | 항암화학요법 |
|---|---|---|---|
| 설명 | 화학적 물질을 이용하여 암을 치료하는 것을 말한다. 이때 사용되는 물질을 항암제라고 한다. 이상적인 항암제는 정상적인 세포에는 이상이 없고 단지 암세포에만 치명적인 효과를 나타내어야 한다. 이렇게 하려면 암세포만의 특이한 특성을 이해하고 그곳에만 작용하는 약물을 개발하여야 한다. 최근 대부분의 항암제는 암세포가 정상 세포에 비하여 월등히 증식을 빨리한다는 특성을 이용하고 있다. 증식이 빠르다는 것은 유전정보를 가지고 있는 DNA의 복제가 빠르다는 것을 의미한다. 만약 DNA의 복제를 방해한다면 증식이 아주 빠른 암세포에게는 치명적이지만 영원히 증식을 하지 않는(DNA의 복제가 거의 필요없는)신경세포나 증식이 암세포에 비해서 아주 느린 정상세포에서는 거의 영향을 주지 못한다. 하지만 신체에서도 정상적으로 증식이 암세포와 비슷한 수준으로 일어나는 세포가 있는데 그것은 머리카락을 만드는 모낭세포와 소화관의 점막을 이루는 세포와 혈액의 세포를 만드는 골수 세포이다. 그러므로 항암제를 사용할 경우 이런 세포가 암세포와 마찬가지로 치명적인 영향을 입을 것은 당연하다(그래서 항암제 치료시엔 머리가 빠지고 소화불량이 잘온다). |
||
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
|---|---|
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
| ICR | [distance between] iliac crests; Institute for Cancer Research; Institute for Cancer Research [mouse... |
| MBC | male breast cancer; maximal bladder capacity; maximal breathing capacity; metastatic breast cancer; ... |
| SVCP | Special Virus Cancer Program |
| National Formulary | An official compendium formerly issued by the American Pharmaceutical Association but now published by the United States Pharmacopeial Convention for the purpose of providing standards and specifications which can be used to evaluate the quality of pharmaceuticals and therapeutic agents. (05 Mar 2000) |
|---|---|
| national health planning information centre | A centre in the health resources administration division of planning methods and technology which provides access to current information on health planning and resources development. (12 Dec 1998) |
| national health programs | Components of a national health care system which administer specific services, e.g., national health insurance. (12 Dec 1998) |
| national institute for occupational safety and health | An institute of the centres for disease control and prevention which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals. (12 Dec 1998) |
| national institute of mental health | A component of the national institutes of health concerned with research, overall planning, promoting, and administering mental health programs and research. (12 Dec 1998) |
| National Institutes of Health | <organisation> A nonregulatory U.S. Federal agency which has oversight of research activities that the agency funds. (09 Oct 1997) |
| national library of medicine | An agency of the national institutes of health concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine. (12 Dec 1998) |
| national practitioner data bank | A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like. (12 Dec 1998) |
| National Science Foundation | <organisation> A nonregulatory U.S. Federal agency which has oversight of biotechnology research activities that the agency funds. (09 Oct 1997) |
| united states national aeronautics and space administration | An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. (12 Dec 1998) |
| los alamos national laboratory | <radiobiology> Major DOE research facility, located in Los Alamos, new Mexico, about an hour west of Santa Fe. Former home of a frozen-deuterium-fibre Z-pinch device, which was dismantled. Home to an active theory division, including the Numerical Tokamak Grand Challenge (being performed on the CM-5 massively-parallel supercomputer). Also home to former alternative-concepts experimental devices like Scyllac, FRX-A, FRX-B, FRX-C/LSM, ZT40, and the aborted CPRF which was killed in 1991 when it was almost complete (budget cuts). Currently there are some small in-house experiments, including one on electrostatic confinement as a possible fusion device, and/or a compact neutron source. They also do theory and experimental collaboration with other labs worldwide. (09 Oct 1997) |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
| bone cancer | <oncology> A general term to imply malignant tumour growth in bone. (27 Sep 1997) |